October 6, 2026
Share
Last Updated: 6/10/2026
Glucophage is a brand name for metformin, a prescription medicine mainly used to help control blood glucose in people with type 2 diabetes.
It is available in different strengths and formulations. A higher number on the tablet does not automatically mean a better treatment. The prescribed dose depends on blood glucose control, kidney function, tolerance, the formulation used and other medicines.
One distinction is especially important: 500 mg, 750 mg and 1000 mg describe the amount of metformin in a tablet, while XR describes how the medicine is released.
Glucophage contains metformin hydrochloride, a medicine from the biguanide group.
Metformin lowers blood glucose mainly by reducing glucose production by the liver and helping the body respond more effectively to insulin. It also has an effect on glucose absorption from the digestive tract.
Unlike medicines that directly stimulate insulin release, metformin used on its own does not usually cause significant hypoglycemia. The risk can increase when it is combined with insulin or certain other glucose-lowering medicines.
Glucophage is primarily used to improve blood glucose control in type 2 diabetes.
It may be prescribed alone or together with other diabetes medicines or insulin, depending on the patient's treatment plan. Diet, physical activity and regular monitoring remain important parts of diabetes management.
Yes. Metformin may be used for some people with polycystic ovary syndrome (PCOS), particularly when insulin resistance or abnormal glucose metabolism is part of the clinical picture.
However, this is not appropriate for every patient with PCOS. Regulatory status also differs between countries. NICE, for example, classifies metformin use for PCOS as off-label in the UK.
Some people taking metformin experience modest weight loss or avoid the weight gain associated with some other diabetes treatments. However, Glucophage is not primarily a weight-loss medicine and should not be taken without a medical indication for this purpose.
Mayo Clinic notes that metformin may be associated with modest weight loss in some patients rather than weight gain.
The numbers describe the amount of metformin hydrochloride in the tablet. XR means extended release, which changes how gradually the medicine is released.
|
Product or Strength |
What It Means |
Key Point |
|---|---|---|
|
Glucophage 500 mg |
Tablet containing 500 mg of metformin |
The strength alone does not determine how many tablets or doses are needed |
|
Glucophage 1000 mg |
Tablet containing 1000 mg of metformin |
A higher strength is not automatically better |
|
Glucophage XR 500 mg |
500 mg extended-release tablet |
Releases metformin more gradually |
|
Glucophage XR 750 mg |
750 mg extended-release tablet |
Available in some markets, including Saudi Arabia |
|
Glucophage XR 1000 mg |
1000 mg extended-release tablet |
Used as part of an individualized extended-release regimen |
The Saudi Food and Drug Authority currently lists Glucophage XR 750 mg as an active, marketed prescription product and also lists Glucophage XR 1000 mg. Availability and formulations may differ between countries.
The main difference is the amount of metformin in each tablet.
A 1000 mg tablet is not inherently more effective for every patient. Doctors may use different tablet strengths to reach the required total daily dose while considering tolerability and the number of doses needed.
Regular or immediate-release metformin releases the medicine more quickly. Glucophage XR releases metformin gradually over a longer period.
This can change how often the medicine is taken and when it is taken. The formulation therefore matters as much as the number printed on the tablet.
There is no single Glucophage dose that is appropriate for everyone.
The dose is selected according to the formulation, reason for treatment, blood glucose response, kidney function, gastrointestinal tolerance and other medicines being used.
Current prescribing information commonly starts treatment at a relatively low dose and increases it gradually to improve tolerance. For example, some immediate-release product information starts adults at 500 mg twice daily or 850 mg once daily with meals. Extended-release metformin commonly starts at 500 mg once daily with the evening meal, followed by gradual increases when required. These are prescribing-label examples, not personalized dosing instructions.
Metformin is generally taken with food.Taking it with a meal can reduce nausea, diarrhea and other gastrointestinal symptoms. The exact timing depends on the formulation and prescription.
No. Extended-release metformin tablets should generally be swallowed whole.
Current extended-release prescribing information advises against crushing, cutting or chewing the tablets because this can interfere with the intended release mechanism.
Do not take two doses at the same time to compensate for a forgotten dose.
If it is nearly time for the next scheduled dose, the missed dose is generally skipped and the normal schedule resumed. Follow the instructions provided with your specific medicine.
Metformin does not usually produce a sensation that tells you it has started working.
Blood glucose may begin to improve during the first days or week of treatment, while longer-term measures such as HbA1c require substantially more time to reflect the effect. Treatment is therefore assessed using blood glucose measurements and follow-up rather than by whether you can “feel” the medicine working.
Digestive symptoms are the most common side effects of metformin, particularly when treatment begins or the dose is increased.
Common problems include nausea, diarrhea, vomiting, abdominal discomfort, reduced appetite and changes in taste. Taking the medicine with food and increasing the dose gradually may improve gastrointestinal tolerance.
Yes. Long-term metformin treatment can reduce vitamin B12 levels in some patients.
The UK Medicines and Healthcare products Regulatory Agency advises that the risk increases with higher doses, longer treatment and existing risk factors for vitamin B12 deficiency. Testing may be appropriate when symptoms such as unexplained fatigue, anemia or new numbness and tingling develop.
Finding a low B12 level does not automatically mean metformin must be stopped. The deficiency can often be treated while the need for metformin is reviewed clinically.
Metformin-associated lactic acidosis is rare but serious.
Risk increases in circumstances that can cause metformin to accumulate or reduce oxygen delivery, including severe kidney impairment and certain severe acute illnesses. Symptoms such as unusual breathing difficulty, severe weakness, persistent vomiting, marked abdominal symptoms or rapid deterioration require urgent medical assessment.
Metformin is not generally described as a medicine that directly damages healthy kidneys. However, kidney function is critical to its safe use because metformin is cleared from the body through the kidneys.
Kidney function should therefore be assessed before treatment and monitored when appropriate.
Current U.S. prescribing information contraindicates metformin when eGFR is below 30 mL/min/1.73 m² and does not recommend starting it when eGFR is between 30 and 45 mL/min/1.73 m².
Some patients may also need to stop metformin temporarily around certain imaging procedures that use iodinated contrast. The decision depends on kidney function and other risk factors, so patients should tell the medical team that they take metformin before the procedure.
Contact your doctor or pharmacist if you develop significant vomiting or diarrhea, dehydration, a severe infection or another acute illness that makes it difficult to eat or drink normally.
Medical advice is also important if kidney function worsens, gastrointestinal side effects remain severe, symptoms suggest possible vitamin B12 deficiency, or you are scheduled for certain contrast imaging procedures or surgery.
Urgent assessment is needed for severe or unusual symptoms such as breathing difficulty, profound weakness, persistent vomiting or rapid deterioration.
Metformin can be used during pregnancy in appropriate clinical situations, but treatment should be managed by a healthcare professional.
Good glucose control during pregnancy is important for both the mother and baby. Patients should therefore not start or stop Glucophage simply because they become pregnant without discussing the treatment plan with their doctor.
The NHS also states that metformin can usually be used during breastfeeding because only small amounts pass into breast milk.
Do not stop prescribed Glucophage on your own when it is being used to control diabetes.
Stopping treatment can allow blood glucose to rise. In some situations, however, a clinician may recommend temporarily withholding metformin, such as during significant dehydration, certain acute illnesses or specific medical procedures.
If nausea, diarrhea or another side effect is making the medicine difficult to tolerate, ask your doctor about the dose or formulation rather than discontinuing it without advice.
Glucophage is a metformin medicine used primarily to manage type 2 diabetes. Its 500 mg, 750 mg and 1000 mg strengths describe the amount of metformin, while XR identifies an extended-release formulation. The right dose depends on glucose control, kidney function, tolerance and the specific product. Persistent side effects, dehydration, kidney problems or unusual severe symptoms should be discussed with a healthcare professional rather than managed by changing the dose independently.
Medical Review: The rebuilt English version should undergo final clinical review before publication.
Disclaimer: This article is intended for health education only and is not a substitute for consultation with a qualified healthcare professional.

The Magrabi Health Editorial Team creates educational medical content designed to help readers better understand symptoms, diagnostic tests, treatment options, and preventive healthcare measures across a wide range of medical topics, drawing on trusted sources and specialized clinical expertise. Since 1955, Magrabi Health has built more than 70 years of experience in specialized healthcare through a regional network of over 40 facilities across 5 countries. Its commitment to quality and patient safety is reflected in numerous accreditations and recognitions, including the designation of several eye centers as Centers of Excellence in Ophthalmology by the Surgical Review Corporation (SRC). This content is intended for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Glucophage contains metformin and is mainly used to improve blood glucose control in type 2 diabetes. Metformin may also be used in other situations, including selected cases of PCOS or diabetes during pregnancy, depending on clinical assessment and local prescribing rules.
Yes. Glucophage is a brand name for a medicine containing metformin hydrochloride. Other brands and generic metformin products may also be available.
They contain different amounts of metformin per tablet. The 1000 mg tablet is not automatically a better option. The strength and number of tablets are selected to achieve the prescribed total dose.
Both contain metformin. Glucophage XR is an extended-release formulation that releases the medicine more gradually, so the dosing schedule may differ from immediate-release tablets.
Metformin is usually taken with food to reduce stomach-related side effects. Follow the instructions for your specific formulation because timing may differ between regular and extended-release products.
Glucophage is not a weight-loss medicine. Some patients may experience modest weight loss while taking metformin, but it should not be used solely for weight reduction without an appropriate medical reason.